Clinical Trial Update: TB006 Expanded Access (EA) Compassionate Use

View source ↗

Summary

TB006 is being offered under expanded access/compassionate use for Alzheimer's disease, sponsored by TrueBinding, Inc. The program status is AVAILABLE.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• TB006

Snippet

Sponsor: TrueBinding, Inc. | Conditions: Alzheimer Disease | Status: AVAILABLE